Terns Pharmaceuticals Files 8-K Report
Ticker: TERN · Form: 8-K · Filed: Apr 27, 2026 · CIK: 0001831363
| Field | Detail |
|---|---|
| Company | Terns Pharmaceuticals, Inc. (TERN) |
| Form Type | 8-K |
| Filed Date | Apr 27, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, SEC filing
TL;DR
Terns Pharma dropped an 8-K on 4/27/26 - check the exhibits for the deets.
AI Summary
On April 27, 2026, Terns Pharmaceuticals, Inc. filed an 8-K report detailing events under Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The filing includes an interactive data document and exhibits such as EX-99.1, which likely contains important company information.
Why It Matters
This 8-K filing signals that Terns Pharmaceuticals has made a significant disclosure to the SEC, potentially impacting investors' understanding of the company's current status and future prospects.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report, indicating routine corporate disclosures rather than immediate, high-impact events.
Key Numbers
- 35356 — iXBRL 8-K Size (Size of the interactive data document in bytes.)
- 12219 — EX-99.1 Size (Size of Exhibit 99.1 in bytes.)
Key Players & Entities
- Terns Pharmaceuticals, Inc. (company) — Filer of the 8-K report
- 0001831363 (company) — CIK number for Terns Pharmaceuticals, Inc.
- 2026-04-27 (date) — Filing date and period of report
FAQ
What specific information is contained within Exhibit 99.1?
Exhibit 99.1 (d122087dex991.htm) is an exhibit to the 8-K filing, and its content would need to be reviewed to determine the specific information it provides.
What is the purpose of Item 7.01 (Regulation FD Disclosure)?
Item 7.01 is used to disclose any material nonpublic information that the company intends to make available to security holders.
What does the filing indicate about Terns Pharmaceuticals' financial statements?
Item 9.01 of the filing indicates that Financial Statements and Exhibits are being provided, suggesting updates or relevant financial information is included.
What is the significance of the filing date April 27, 2026?
The filing date of April 27, 2026, signifies the official date Terns Pharmaceuticals submitted this report to the SEC, and it also represents the period of report.
What is the company's SIC code and its classification?
The company's SIC code is 2834, which classifies it under Pharmaceutical Preparations, within the Life Sciences sector.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 27, 2026 regarding Terns Pharmaceuticals, Inc. (TERN).